Biotech

All Articles

Nuvation stops wager inhibitor after taking into consideration phase 1 record

.After having a look at period 1 data, Nuvation Bio has actually chosen to halt work on its own one-...

' Clinical instinct' led FDA consultants to support Zevra's rare disease med

.Zevra Therapies' uncommon ailment medicine appears to become on the pathway to approval this fall a...

Pfizer takes $230M attacked after axing stopped working DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene therapy breakdown has blown a $230 thousand ...

AC Immune observes 'landmark' potential in Alzheimer's medication data

.After greater than 20 years of focus on neurodegenerative conditions, Swiss biotech AC Immune claim...

GSK drops ph. 2 HPV vaccine over absence of best-in-class possible

.GSK has scrapped a period 2 individual papillomavirus (HPV) injection from its pipe after determini...

OS Treatments refiles $6M IPO to money HER2 medication, preclinical ADCs

.OS Therapies will certainly provide on the NYSE American stock swap this morning via a $6.4 million...

ALX's waning CD47 feedback rate sends out sell spiraling down

.ALX Oncology's phase 2 gastric cancer cells response rate has weakened. After seeing its CD47 block...

Ionis centers eye condition coming from intendeds of Roche-partnered prospect after data dissatisfy

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of assu...

Biogen's CEO pointed out no risky deals in 2023. He's ready to be strong

.While Biogen's pharma peers are actually searching for late-stage properties along with little bit ...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Biography has actually been actually a biotech searching for a pipe after it junked its own ...